171 related articles for article (PubMed ID: 36320325)
1. Epigenetic regulation of
Pilala KM; Papadimitriou MA; Panoutsopoulou K; Barbarigos P; Levis P; Kotronopoulos G; Stravodimos K; Scorilas A; Avgeris M
Mol Ther Nucleic Acids; 2022 Dec; 30():311-322. PubMed ID: 36320325
[TBL] [Abstract][Full Text] [Related]
2.
Pilala KM; Kotronopoulos G; Levis P; Giagkos GC; Stravodimos K; Vassilacopoulou D; Scorilas A; Avgeris M
JCO Precis Oncol; 2024 Apr; 8():e2300414. PubMed ID: 38579191
[TBL] [Abstract][Full Text] [Related]
3. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
Avgeris M; Tsilimantou A; Levis PK; Rampias T; Papadimitriou MA; Panoutsopoulou K; Stravodimos K; Scorilas A
Carcinogenesis; 2019 Aug; 40(8):965-974. PubMed ID: 30815670
[TBL] [Abstract][Full Text] [Related]
4. tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5'-tRF-LysCTT Results in Disease Early Progression and Patients' Poor Treatment Outcome.
Papadimitriou MA; Avgeris M; Levis P; Papasotiriou EC; Kotronopoulos G; Stravodimos K; Scorilas A
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291319
[TBL] [Abstract][Full Text] [Related]
5. miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.
Tsikrika FD; Avgeris M; Levis PK; Tokas T; Stravodimos K; Scorilas A
Genes Chromosomes Cancer; 2018 Mar; 57(3):150-161. PubMed ID: 29181884
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study.
Xiao Y; Ju L; Qian K; Jin W; Wang G; Zhao Y; Jiang W; Liu N; Wu K; Peng M; Cao R; Li S; Shi H; Gong Y; Zheng H; Liu T; Luo Y; Ma H; Chang L; Li G; Cao X; Tian Y; Xu Z; Yang Z; Shan L; Guo Z; Yao D; Zhou X; Chen X; Guo Z; Liu D; Xu S; Ji C; Yu F; Hong X; Luo J; Cao H; Zhang Y; Wang X
Clin Transl Med; 2022 Aug; 12(8):e1008. PubMed ID: 35968916
[TBL] [Abstract][Full Text] [Related]
7. ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
Papadimitriou MA; Avgeris M; Levis PK; Tokas T; Stravodimos K; Scorilas A
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3075-3087. PubMed ID: 31595333
[TBL] [Abstract][Full Text] [Related]
8. Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients.
Avgeris M; Tsilimantou A; Levis PK; Tokas T; Sideris DC; Stravodimos K; Ardavanis A; Scorilas A
Br J Cancer; 2018 Dec; 119(12):1477-1486. PubMed ID: 30374124
[TBL] [Abstract][Full Text] [Related]
9. Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.
Martins-Lima C; Miranda-Gonçalves V; Lobo J; Constâncio V; Leite-Silva P; Guimarães-Teixeira C; Monteiro-Reis S; Sequeira JP; Cantante M; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
Cell Oncol (Dordr); 2022 Feb; 45(1):135-149. PubMed ID: 35064910
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome.
Papadimitriou MA; Levis P; Kotronopoulos G; Stravodimos K; Avgeris M; Scorilas A
Clin Chem; 2023 Apr; 69(4):399-410. PubMed ID: 36738246
[TBL] [Abstract][Full Text] [Related]
11. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
13. Global analysis of miRNA-mRNA regulation pair in bladder cancer.
Fan X; Zou X; Liu C; Peng S; Zhang S; Zhou X; Wang T; Zhu W
World J Surg Oncol; 2022 Mar; 20(1):66. PubMed ID: 35241117
[TBL] [Abstract][Full Text] [Related]
14. Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.
Avgeris M; Mavridis K; Tokas T; Stravodimos K; Fragoulis EG; Scorilas A
Carcinogenesis; 2015 May; 36(5):528-37. PubMed ID: 25804644
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of DNA repair genes as promising prognostic and predictive biomarkers in urothelial bladder carcinoma patients.
Mohanad M; Yousef HF; Bahnassy AA
Mol Genet Genomics; 2022 Nov; 297(6):1671-1687. PubMed ID: 36076047
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Small Heat Shock Protein Family Members
Gianniou DD; Sklirou AD; Papadimitriou MA; Pilala KM; Stravodimos K; Avgeris M; Scorilas A; Trougakos IP
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768927
[TBL] [Abstract][Full Text] [Related]
17. A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.
Guo Y; Yin J; Dai Y; Guan Y; Chen P; Chen Y; Huang C; Lu YJ; Zhang L; Song D
Front Cell Dev Biol; 2021; 9():642650. PubMed ID: 34540821
[TBL] [Abstract][Full Text] [Related]
18. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
19. Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition.
Monteiro-Reis S; Miranda-Gonçalves V; Guimarães-Teixeira C; Martins-Lima C; Lobo J; Montezuma D; Dias PC; Neyret-Kahn H; Bernard-Pierrot I; Henrique R; Jerónimo C
Int J Biol Sci; 2023; 19(1):1-12. PubMed ID: 36594099
[TBL] [Abstract][Full Text] [Related]
20. miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.
Papadimitriou MA; Soureas K; Papanota AM; Tsiakanikas P; Adamopoulos PG; Ntanasis-Stathopoulos I; Malandrakis P; Gavriatopoulou M; Sideris DC; Kastritis E; Avgeris M; Dimopoulos MA; Terpos E; Scorilas A
J Transl Med; 2023 Apr; 21(1):245. PubMed ID: 37024879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
